Disclosure 0001842190-26-000009-1

SEC FORM 4

$339,829.86

Tarsus Pharmaceuticals, Inc. (TARS)

Sale of 4,601 shares at $73.86 per share.

Reporting Person Lin Elizabeth Yeu · Officer Title Chief Medical Officer · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001842190-26-000009 · filed 2026-09-03 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Tarsus Pharmaceuticals, Inc. (TARS)." Disclosed 2026-09-03. https://desqlong.com/cards/0001842190-26-000009-1 (retrieved 2026-09-26).